Japan Hormone Replacement Therapy Market Size & Outlook

The hormone replacement therapy market in Japan is expected to reach a projected revenue of US$ 1,911.3 million by 2030. A compound annual growth rate of 6.1% is expected of Japan hormone replacement therapy market from 2023 to 2030.
Revenue, 2022 (US$M)
$1,192.7
Forecast, 2030 (US$M)
$1,911.3
CAGR, 2023 - 2030
6.1%
Report Coverage
Japan

Japan hormone replacement therapy market, 2018-2030 (US$M)

Japan

Japan hormone replacement therapy market highlights

  • The Japan hormone replacement therapy market generated a revenue of USD 1,192.7 million in 2022 and is expected to reach USD 1,911.3 million by 2030.
  • The Japan market is expected to grow at a CAGR of 6.1% from 2023 to 2030.
  • In terms of segment, estrogen and progesterone replacement therapy was the largest revenue generating product in 2022.
  • Parathyroid Hormone replacement is the most lucrative product segment registering the fastest growth during the forecast period.


Hormone replacement therapy market data book summary

Market revenue in 2022USD 1,192.7 million
Market revenue in 2030USD 1,911.3 million
Growth rate6.1% (CAGR from 2022 to 2030)
Largest segmentEstrogen and progesterone replacement therapy
Fastest growing segmentParathyroid Hormone replacement
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationEstrogen and Progesterone Replacement Therapy, HGH replacement therapy, Thryoid hormone replacement therapy, Testosterone Replacement Therapy, Parathyroid Hormone replacement
Key market players worldwideEli Lilly and Co, Bayer AG, Hisamitsu Pharmaceutical Co Inc, Pfizer Inc, Merck & Co Inc, Viatris Inc, Novo Nordisk A/S ADR, AbbVie Inc, Roche Holding AG ADR, Ascend Wellness Holdings Inc


Other key industry trends

  • In terms of revenue, Japan accounted for 5.6% of the global hormone replacement therapy market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan hormone replacement therapy market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,698.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hormone Replacement Therapy Market Companies

Name Profile # Employees HQ Website

Japan hormone replacement therapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormone replacement therapy market will help companies and investors design strategic landscapes.


Estrogen and progesterone replacement therapy was the largest segment with a revenue share of 53.41% in 2022. Horizon Databook has segmented the Japan hormone replacement therapy market based on estrogen and progesterone replacement therapy, hgh replacement therapy, thryoid hormone replacement therapy, testosterone replacement therapy, parathyroid hormone replacement covering the revenue growth of each sub-segment from 2018 to 2030.


In Japan, the market for hormone replacement therapy is growing over the forecast period due to the rising prevalence of conditions such as menopause & hypothyroidism. According to an article published in International Journal of Epidemiology, (February 2021), the percentage of women using hormone replacement therapy during the followup period, the proportion of hormone replacement therapy users who stopped the therapy before the baseline survey, the percentage of all participants who had used hormone replacement therapy for 2 years were 10.6%, 3.2%, and 13.8%, respectively.

Furthermore, according to the Japan Society of Obstetrics and Gynecology annual report (2021), hormone replacement therapy is used as a first-line treatment option in patients with surgical menopause. In addition, estrogen and progesterone replacement therapy are used to treat symptoms associated with menopause.

Reasons to subscribe to Japan hormone replacement therapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan hormone replacement therapy market databook

  • Our clientele includes a mix of hormone replacement therapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan hormone replacement therapy market , including forecasts for subscribers. This country databook contains high-level insights into Japan hormone replacement therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan hormone replacement therapy market size, by product, 2018-2030 (US$M)

Japan Hormone Replacement Therapy Market Outlook Share, 2022 & 2030 (US$M)

Japan hormone replacement therapy market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more